Home » GE Healthcare

GE Healthcare

Dec 31, 2015

NeoGenomics Completes Clarient Acquisition

The cancer genetics testing provider acquired its new business unit from GE Healthcare.

Oct 28, 2015

With Clarient Purchase, NeoGenomics Hoping to Offer Most Comprehensive Cancer Genetics Test Menu

Premium

By buying Clarient, NeoGenomics hopes to move closer to its goal of becoming America's top cancer genetic testing lab.

Oct 21, 2015

NeoGenomics to Acquire Clarient From GE

NeoGenomics and GE Healthcare will also collaborate on a bioinformatics initiative for personalized oncology.

Jul 14, 2015

Axiogenesis Inks Sublicensing Agreement with GE Healthcare for Stem Cell IP

The deal gives Axiogenesis access to IP that will allow it to commercialize stem cell-derived assays and disease models for use in drug discovery.

Dec 04, 2014

Broad Licenses CRISPR/Cas9 IP to GE Healthcare, Sigma-Aldrich

The licenses provide non-exclusive access to the IP for research applications.

Nov 04, 2014

IP Roundup: GE, Luminex, and University of Tokyo Win US Patents

Premium

General Electric has been awarded

Oct 08, 2014

GE/Clarient Setting Up Lab Network, Database to Advance Personalized Rx for GSK, Other Pharmas

Premium

Originally published Oct. 3.

Sep 30, 2014

GE Healthcare's Clarient, GSK Creating Clinical Lab Network to Improve Cancer Dx

NEW YORK (GenomeWeb) – GE Healthcare today announced a deal between its affiliate Clarient Diagnostic Services and GlaxoSmithKline to create a network of clinical laboratories to identify genetic mutations associated with different tumor types.

Sep 25, 2014

IP Update: Recent Patents Awarded to Alnylam, GE Healthcare, Sanofi, and More

Premium

Title: Treatment of Cancer by Inhibition of IGFBPs and Clusterin
Patent Number: 8,835,401
Filed: May 29, 2013

Sep 04, 2014

Product Watch: GE Healthcare Illustra Single-Cell DNA Amplification Kit

Premium

GE Healthcare this week launched the illustra Single Cell GenomiPhi DNA amplification kit from.

Pages

The Scan

Not Mentioning It

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

Lost Some Value There

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Slight Budget Trim

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

This Week in PLOS

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.